期刊论文详细信息
Journal of Biomedical Science
Honokiol blocks store operated calcium entry in CHO cells expressing the M3 muscarinic receptor: honokiol and muscarinic signaling
Robert S Aronstam2  Ming-Huan Chan3  Yue-wern Huang2  Adam L Martin2  Rhett A Reichard2  Po-Kuan Chao1  Alexis G Martin2  Hsiu-Jen Wang2 
[1] Department of Life Science, National Taiwan Normal University, 116, Taipei, Taiwan, R O C;Department of Biological Sciences, Missouri University of Science & Technology, 400 W. 11th St, Rolla MO 65409, USA;Institute of Neuroscience, National Chengchi University, Taipei, Taiwan
关键词: Phospholipase Cβ;    Muscarinic acetylcholine receptor;    Inositol trisphosphate (IP3);    Store operated calcium entry (SOCE);    Calcium signaling;    Honokiol;   
Others  :  824273
DOI  :  10.1186/1423-0127-20-11
 received in 2012-12-21, accepted in 2013-02-22,  发布年份 2013
PDF
【 摘 要 】

Background

Honokiol, a cell-permeable phenolic compound derived from the bark of magnolia trees and present in Asian herbal teas, has a unique array of pharmacological actions, including the inhibition of multiple autonomic responses. We determined the effects of honokiol on calcium signaling underlying transmission mediated by human M3 muscarinic receptors expressed in Chinese hamster ovary (CHO) cells. Receptor binding was determined in radiolabelled ligand binding assays; changes in intracellular calcium concentrations were determined using a fura-2 ratiometric imaging protocol; cytotoxicity was determined using a dye reduction assay.

Results

Honokiol had a potent (EC50 ≈ 5 μmol/l) inhibitory effect on store operated calcium entry (SOCE) that was induced by activation of the M3 receptors. This effect was specific, rapid and partially reversible, and was seen at concentrations not associated with cytotoxicity, inhibition of IP3 receptor-mediated calcium release, depletion of ER calcium stores, or disruption of M3 receptor binding.

Conclusions

It is likely that an inhibition of SOCE contributes to honokiol disruption of parasympathetic motor functions, as well as many of its beneficial pharmacological properties.

【 授权许可】

   
2013 Wang et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140713025600565.pdf 1789KB PDF download
Figure 8. 41KB Image download
Figure 7. 42KB Image download
Figure 6. 34KB Image download
Figure 5. 38KB Image download
Figure 4. 41KB Image download
Figure 3. 38KB Image download
Figure 2. 42KB Image download
Figure 1. 32KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】
  • [1]Fried LE, Arbiser JL: Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 2009, 11(5):1139-1148.
  • [2]Dikalov S, Losik T, Arbiser JL: Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 2008, 76(5):589-596.
  • [3]Chao LK, Liao PC, Ho CL, Wang EI, Chuang CC, Chiu HW, Hung LB, Hua KF: Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression. J Agric Food Chem 2010, 58(6):3472-3478.
  • [4]Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park E, Kim J, Park S, Park D: Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med 2005, 71(4):338-343.
  • [5]Lee SY, Cho JY: Inhibitory effects of honokiol on LPS and PMA-induced cellular responses of macrophages and monocytes. BMB Rep 2009, 42(9):574-579.
  • [6]Lin YR, Chen HH, Ko CH, Chan MH: Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci 2007, 81(13):1071-1078.
  • [7]Lin YR, Chen HH, Lin YC, Ko CH, Chan MH: Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain. J Biomed Sci 2009, 16:94. BioMed Central Full Text
  • [8]Chan SS, Zhao M, Lao L, Fong HH, Che CT: Magnolol and honokiol account for the anti-spasmodic effect of magnolia officinalis in isolated guinea pig ileum. Planta Med 2008, 74(4):381-384.
  • [9]Ko CH, Chen HH, Lin YR, Chan MH: Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea. Planta Med 2003, 69(6):532-536.
  • [10]Lu YC, Chen HH, Ko CH, Lin YR, Chan MH: The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus. Naunyn Schmiedebergs Arch Pharmacol 2003, 368(4):262-269.
  • [11]Putney JW: Capacitative calcium entry: from concept to molecules. Immunol Rev 2009, 231(1):10-22.
  • [12]Smyth JT, Hwang SY, Tomita T, Dehaven WI, Mercer JC, Putney JW: Activation and regulation of store-operated calcium entry. J Cell Mol Med 2010, 14(10):2337-2349.
  • [13]Putney JW: Pharmacology of store-operated calcium channels. Mol Interv 2010, 10(4):209-218.
  • [14]Bird GS, DeHaven WI, Smyth JT, Putney JW Jr: Methods for studying store-operated calcium entry. Methods 2008, 46(3):204-212.
  • [15]Wang HJ, Growcock AC, Tang TH, O’Hara J, Huang YW, Aronstam RS: Zinc oxide nanoparticle disruption of store-operated calcium entry in a muscarinic receptor signaling pathway. Toxicol In Vitro 2010, 24(7):1953-1961.
  • [16]Varga EV, Stropova D, Rubenzik M, Wang M, Landsman RS, Roeske WR, Yamamura HI: Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur J Pharmacol 1998, 348(2–3):R1-R2.
  • [17]Aronstam RS, Patil P: Muscarinic receptors: autonomic neurons. In Encyclopedia of neuroscience. 4th edition. Edited by Squire LR. Oxford: Academic; 2009:1141-1149.
  • [18]Smyth JT, Dehaven WI, Bird GS, Putney JW Jr: Ca2 + -Store-dependent and -independent reversal of stim1 localization and function. J Cell Sci 2008, 121(Pt 6):762-772.
  • [19]Alexeev M, Grosenbaugh DK, Mott DD, Fisher JL: The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors. Neuropharmacology 2012, 62(8):2507-2514.
  • [20]Tian W, Deng Y, Li L, He H, Sun J, Xu D: Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death. Int J Oncol 2013, 42(2):721-732.
  • [21]Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D: Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res: BCR 2012, 14(1):R35. BioMed Central Full Text
  • [22]Fukuyama Y, Nakade K, Minoshima Y, Yokoyama R, Zhai H, Mitsumoto Y: Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons. Bioorganic Med Chem Lett 2002, 12(8):1163-1166.
  • [23]Ermak G, Davies KJ: Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002, 38(10):713-721.
  • [24]Chen YJ, Wu CL, Liu JF, Fong YC, Hsu SF, Li TM, Su YC, Liu SH, Tang CH: Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cancer Lett 2010, 291(1):20-30.
  文献评价指标  
  下载次数:3次 浏览次数:4次